National Immunization Schedule
National Immunization Schedule India 2025 2026 vaccines
https://nhm.gov.in/New_Updates_2018/NHM_Components/Immunizat…
| Age | Vaccines | Dose | Route | Site |
|---|---|---|---|---|
| Birth | BCG | 0.1 ml (0.05 ml up to 1 month) | Intradermal | Left upper arm |
| OPV-0 | 2 drops | Oral | Oral | |
| Hepatitis B (birth dose) | 0.5 ml | Intramuscular | Anterolateral mid-thigh | |
| 6 Weeks | OPV-1 | 2 drops | Oral | Oral |
| Pentavalent-1 (DPT + Hep B + Hib) | 0.5 ml | Intramuscular | Anterolateral mid-thigh | |
| Rotavirus Vaccine (RVV)-1 | 5 drops / 2.5 ml | Oral | Oral | |
| fIPV-1 (Fractional IPV) | 0.1 ml | Intradermal | Right upper arm | |
| PCV-1* | 0.5 ml | Intramuscular | Anterolateral mid-thigh | |
| 10 Weeks | OPV-2 | 2 drops | Oral | Oral |
| Pentavalent-2 | 0.5 ml | Intramuscular | Anterolateral mid-thigh | |
| RVV-2 | 5 drops | Oral | Oral | |
| 14 Weeks | OPV-3 | 2 drops | Oral | Oral |
| Pentavalent-3 | 0.5 ml | Intramuscular | Anterolateral mid-thigh | |
| fIPV-2 | 0.1 ml | Intradermal | Right upper arm | |
| RVV-3 | 5 drops | Oral | Oral | |
| PCV-2* | 0.5 ml | Intramuscular | Anterolateral mid-thigh | |
| 9-12 Months | MR-1 (Measles-Rubella) | 0.5 ml | Subcutaneous | Right upper arm |
| JE-1** | 0.5 ml | SC (live) / IM (killed) | Left upper arm (live) / mid-thigh (killed) | |
| PCV Booster* | 0.5 ml | Intramuscular | Anterolateral mid-thigh | |
| Vitamin A (1st dose) | 1 ml (1 lakh IU) | Oral | Oral |
| Age | Vaccines | Dose | Route | Site |
|---|---|---|---|---|
| 16-24 Months | MR-2 | 0.5 ml | Subcutaneous | Right upper arm |
| JE-2** | 0.5 ml | SC / IM | Left upper arm / mid-thigh | |
| DPT Booster-1 | 0.5 ml | Intramuscular | Anterolateral mid-thigh | |
| OPV Booster | 2 drops | Oral | Oral | |
| Vitamin A (2nd-9th dose) | 2 ml (2 lakh IU), every 6 months up to 5 years | Oral | Oral | |
| 5-6 Years | DPT Booster-2 | 0.5 ml | Intramuscular | Upper arm |
| 10 Years | Td (Tetanus-diphtheria) | 0.5 ml | Intramuscular | Upper arm |
| 16 Years | Td | 0.5 ml | Intramuscular | Upper arm |
| Timing | Vaccine | Dose | Route | Site |
|---|---|---|---|---|
| Early in pregnancy (1st ANC visit) | Td-1 | 0.5 ml | Intramuscular | Upper arm |
| 4 weeks after Td-1 | Td-2 | 0.5 ml | Intramuscular | Upper arm |
| If previously vaccinated with 2 Td/TT doses within last 3 years | Td-Booster | 0.5 ml | Intramuscular | Upper arm |
| Vaccine | Schedule |
|---|---|
| MMR | 15 months, 4-6 years |
| Varicella | 15 months (or after 1 year) |
| Typhoid conjugate (TCV) | 9-12 months, then booster at 2 years |
| Hepatitis A | 12 months + booster at 18 months (killed) / single dose (live) |
| Influenza | 6 months onwards, annually |
| HPV | 9-14 years (2 doses); 15+ years (3 doses) |
| Meningococcal | High-risk groups |